This amendment provides for a 4.00Yo reduction in intermediate care facility for individuals with intellectual disabilities (lCF/IID) payment rates.

This amendment provides for a 4.00% reduction in inpatient hospital payment rates other than Diagnosis Related Group (DRG) and DRG outlier payment rates for all hospitals other than critical access hospitals, hospitals located in frontier, rural and densely settled rural counties, and state-operated psychiatric hospitals.

This amendment provides for a 4,00% reduction in psychiatric residential treatment facility (PRTF) payment rates.

This amendment reduces base Nursing Facility payment rates by 4.0%. This SPA also updates charts and exhibits within the state plan that demonstrate the revised factors and limits applicable to the rate period begiming with SFY 2016. The SPA also updates State Administrative Regulations tllat are included as attachments to the Plan.

Adds a new payment methodology for services provided in an ambulatory surgery setting.

This SPA proposes programmatic changes in the provision of Community Mental Health Rehabilitative Services in order to ensure appropriate utilization, provider qualifications, and cost efficiency appropriate to render these Medicaid covered services.

The SPA was submitted to allow the Mississippi Division of Medicaid to cover Autism Spectrum Disorder (ASD) services Early and Periodic Screening, Diagnosis and Treatment (EPSDT)-eligible beneficiaries when medically necessary, prior authorized and provided by certain qualified providers operating within their scope of practice, effective January 1, 2017.

This SPA removes the requirement that functional assessments be conducted in a consumer's home and also provides clarification on the two programs of Personal Care Services (agency-based and consumer- directed), and the provider qualifications for each.

This SPA amends and updates the State's APG system for Outpatient Hospital Services.

This SPA updates Maryland's State Plan to update covered outpatient drugs to include agents when used for cosmetic purposes or hair growth when medically necessary.